Heart failure represents a complex clinical syndrome and a final common pathway for numerous cardiovascular diseases. It substantially contributes to mortality, disability, and escalating healthcare expenditures globally. while age-standardized mortality rates (ASMRs) have dramatically decreased for most cardiovascular conditions since the 1970s, heart failure’s ASMR has stagnated or even risen in certain regions.
Illustrating this trend, data from the United States reveals a stark contrast between 1970 and 2022. During this period,the ASMR for acute myocardial infarction declined by 89%,for ischemic heart disease by 81%,and for all heart disease combined by 66%. however, the ASMR for heart failure increased by 146% .
This counter-trend is attributed to several factors, including an aging population, improved survival rates after acute cardiac events leading to a larger pool of individuals at risk of developing heart failure, and possibly, improved diagnosis and reporting of the condition. The increasing prevalence of risk factors such as hypertension, diabetes, and obesity also plays a crucial role .
The rising incidence of heart failure despite advancements in treating other cardiovascular diseases underscores the need for greater focus on prevention, early detection, and innovative therapeutic strategies. Research continues to explore new treatments and management approaches to address this growing public health challenge .
